Richard Daniell, Executive VP, European Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 117,904 shares at $7.37 ($877K) on 2022-03-07, disclosed to the SEC on 2022-03-08.
Seasonal sale ($877k) by Executive VP, European Commercial — this insider has traded TEVA in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.48 | 15,920 | $119K | 13.6% |
| 2 | $7.48 | 15,920 | $119K | 13.6% |
| 3 | $7.48 | 20,456 | $153K | 17.4% |
| 4 | $7.48 | 20,456 | $153K | 17.4% |
| 5 | $7.37 | 22,576 | $166K | 19.0% |
| 6 | $7.37 | 22,576 |
| $166K |
| 19.0% |
| Total | $7.44 avg | 117,904 | $877K | 100% |
| Filing → |
| TEVA | SELL | 2026-03-06 | $6.0M | — | Filing → |
| TEVA | SELL | 2026-03-05 | $8.3M | — | Filing → |
| TEVA | SELL | 2025-12-11 | $6.6M | — | Filing → |